F Douglas Kling

Affiliations

  • Chief Operating Officer at Newamsterdam Pharma Co N.v. (NAMS), 2025-01-31
  • See Remarks at Matinas Biopharma Holdings Inc. (MTNB), 2017-03-01
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
NAMS $0.00 8,914 44,000 2025-01-30 Filing
NAMS $0.00 4,664 52,914 2025-01-30 Filing
NAMS $0.00 56,863 44,000 2025-01-29 Filing
NAMS $0.00 5,148 44,000 2025-01-28 Filing
NAMS $0.00 20,237 49,148 2025-01-28 Filing